• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短篇通讯:HIV 治愈研究中的人群代表性:对美国开展的 HIV 治愈研究中多样性的综述。

Short Communication: Population Representation in HIV Cure Research: A Review of Diversity Within HIV Cure Studies Based in the United States.

机构信息

Department of Epidemiology, Milken Institute School of Public Health at the George Washington University, District of Columbia, USA.

Community Education Group, Inc., District of Columbia, USA.

出版信息

AIDS Res Hum Retroviruses. 2022 Aug;38(8):631-644. doi: 10.1089/AID.2021.0127. Epub 2022 Feb 21.

DOI:10.1089/AID.2021.0127
PMID:35018803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9464046/
Abstract

HIV is experienced across diverse populations, with gender and racial/ethnic minority populations bearing a significant proportion of disease. With National Institutes of Health (NIH) placing a priority on the enrollment of women and racial/ethnic minorities into studies, it is important to understand the diversity of participants in research. We sought to characterize how HIV cure research studies report data on diversity. A sampling frame of publications with funding provided by the Martin Delaney Collaboratories for HIV Research in 2019 was reviewed for reporting of demographic data. Of 55 publications that included research on humans/human specimens, only 51% provided any demographic description. There often is insufficient consideration of diversity of populations in HIV cure research. Ameliorating gaps in this regard will require recruitment of diverse populations/specimens and specifications to report demographic data in articles. This will ensure inclusion of diverse participants in HIV cure research from earliest laboratory to eventual phase III studies.

摘要

艾滋病毒影响着不同人群,其中性别和少数族裔人群承担着相当大比例的疾病负担。美国国立卫生研究院 (NIH) 将重点放在将女性和少数族裔纳入研究中,因此了解研究参与者的多样性非常重要。我们试图描述艾滋病毒治愈研究报告多样性数据的方式。对 2019 年马丁·德莱尼艾滋病毒研究合作体资助的出版物抽样框架进行了审查,以报告人口统计数据。在包含人类/人类标本研究的 55 篇出版物中,只有 51%提供了任何人口统计描述。在艾滋病毒治愈研究中,往往没有充分考虑人群的多样性。要弥补这方面的差距,需要招募不同的人群/标本,并规定在文章中报告人口统计数据。这将确保从最早的实验室到最终的 III 期研究,将不同的参与者纳入艾滋病毒治愈研究中。

相似文献

1
Short Communication: Population Representation in HIV Cure Research: A Review of Diversity Within HIV Cure Studies Based in the United States.短篇通讯:HIV 治愈研究中的人群代表性:对美国开展的 HIV 治愈研究中多样性的综述。
AIDS Res Hum Retroviruses. 2022 Aug;38(8):631-644. doi: 10.1089/AID.2021.0127. Epub 2022 Feb 21.
2
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health-Funded Pediatric Clinical Trials.报告和代表参与者的种族和民族在国立卫生研究院资助的儿科临床试验。
JAMA Netw Open. 2023 Aug 1;6(8):e2331316. doi: 10.1001/jamanetworkopen.2023.31316.
3
Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.1988年至2002年美国国立过敏与传染病研究所资助的HIV疫苗试验网络中种族/族裔少数群体的参与情况。
Public Health Rep. 2005 Sep-Oct;120(5):543-8. doi: 10.1177/003335490512000509.
4
Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.提高女性在 HIV 治愈相关研究中的实质性参与度:美国的一项定性访谈研究。
HIV Res Clin Pract. 2023 Aug 8;24(1):2246717.
5
Inclusion and reporting of sex, gender, and race/ethnicity in randomized controlled trials of nonpharmacological treatments for alcohol use disorder: A meta-epidemiologic review.纳入和报告非药物治疗酒精使用障碍的随机对照试验中的性别、性别和种族/民族:一项荟萃流行病学综述。
Alcohol Clin Exp Res. 2022 Jul;46(7):1154-1165. doi: 10.1111/acer.14850. Epub 2022 Jul 29.
6
Current status of inclusion of black participants in neuropsychological studies: A scoping review and call to action.纳入黑人参与神经心理学研究的现状:范围综述与行动呼吁。
Clin Neuropsychol. 2022 Feb;36(2):227-244. doi: 10.1080/13854046.2021.2019314. Epub 2022 Jan 10.
7
Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.考虑在 HIV 治愈相关研究中增加种族、民族、性别和性多样性,包括分析性治疗中断:定性研究。
AIDS Res Hum Retroviruses. 2022 Jan;38(1):50-63. doi: 10.1089/AID.2021.0023. Epub 2021 May 31.
8
Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.艾滋病毒药物临床研究中种族/族裔少数群体及感染艾滋病毒的女性的入组情况。
J Natl Med Assoc. 2007 Mar;99(3):242-50.
9
Disparities in violent fatal injury among racial and ethnic minorities, 2009-2019: a portfolio analysis of United States-National Institutes of Health.2009 - 2019年美国国立卫生研究院种族和族裔少数群体暴力致死伤害差异:一项组合分析
J Public Health Policy. 2023 Sep;44(3):386-399. doi: 10.1057/s41271-023-00418-5. Epub 2023 Jun 13.
10
Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?临床试验中纳入、分析和报告性别及种族/民族:我们是否取得了进展?
J Womens Health (Larchmt). 2011 Mar;20(3):315-20. doi: 10.1089/jwh.2010.2469. Epub 2011 Feb 25.

引用本文的文献

1
Integrating socio-behavioral, ethics, community, and translational science considerations in HIV cure research.在HIV治愈研究中整合社会行为学、伦理学、社区及转化科学考量因素。
Curr Opin HIV AIDS. 2025 Jul 14. doi: 10.1097/COH.0000000000000955.
2
Resolving Challenges in HIV Cure-Related Research: Protocol for a Modified Delphi Consensus-Building Process.解决艾滋病治愈相关研究中的挑战:改进的德尔菲共识构建过程方案
JMIR Res Protoc. 2025 Aug 6;14:e67123. doi: 10.2196/67123.
3
"This Is How I Give Back": Long-Term Survivors on Legacy and HIV Cure Research at the End of Life-A Qualitative Inquiry in the United States.“这就是我回报的方式”:美国临终时关于遗产及艾滋病毒治愈研究的长期幸存者——一项定性调查
Infect Dis Rep. 2025 Jul 4;17(4):78. doi: 10.3390/idr17040078.
4
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility survey.艾滋病重度治疗经历者参与临床试验的意愿及对抗逆转录病毒疗法的期望:一项可行性调查。
HIV Med. 2025 Aug;26(8):1251-1257. doi: 10.1111/hiv.70053. Epub 2025 Jun 8.
5
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.美国费城一项延长分析性治疗中断的 HIV 治愈导向试验中的参与者体验。
HIV Res Clin Pract. 2023 Oct 6;24(1):2267825. Epub 2023 Oct 14.
6
Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS Workforce.早期参与 HIV 研究:评估旨在增加 HIV/AIDS 工作队伍多样性的宾大 CFAR 学者计划。
J Acquir Immune Defic Syndr. 2023 Oct 1;94(2S):S28-S35. doi: 10.1097/QAI.0000000000003260.
7
Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.提高女性在 HIV 治愈相关研究中的实质性参与度:美国的一项定性访谈研究。
HIV Res Clin Pract. 2023 Aug 8;24(1):2246717.
8
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.HIV-1 缓解及单倍体脐带血移植后女性患者的可能治愈
Cell. 2023 Mar 16;186(6):1115-1126.e8. doi: 10.1016/j.cell.2023.02.030.
9
Global Imbalances in Funding Sources for HIV Randomized Control Trials.全球艾滋病随机对照试验资金来源失衡。
AIDS Res Hum Retroviruses. 2023 Feb;39(2):53-56. doi: 10.1089/AID.2022.0068. Epub 2023 Jan 10.
10
Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings.美国不同 HIV 感染者青年群体对参与 HIV 治愈相关研究的风险和获益的认知:定性研究结果。
AIDS Res Hum Retroviruses. 2022 Aug;38(8):649-659. doi: 10.1089/AID.2021.0192. Epub 2022 Jun 28.

本文引用的文献

1
Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.考虑在 HIV 治愈相关研究中增加种族、民族、性别和性多样性,包括分析性治疗中断:定性研究。
AIDS Res Hum Retroviruses. 2022 Jan;38(1):50-63. doi: 10.1089/AID.2021.0023. Epub 2021 May 31.
2
A landscape analysis of HIV cure-related clinical research in 2019.2019年艾滋病治愈相关临床研究的景观分析。
J Virus Erad. 2020 Sep 2;6(4):100010. doi: 10.1016/j.jve.2020.100010. eCollection 2020 Nov.
3
A landscape analysis of HIV cure-related clinical trials and observational studies in 2018.2018年艾滋病治愈相关临床试验和观察性研究的全景分析。
J Virus Erad. 2019 Nov 4;5(4):212-219. doi: 10.1016/S2055-6640(20)30030-3.
4
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.种族/民族和蛋白酶抑制剂的使用影响 AIDS 临床试验组研究 A5202 中 HIV-1 感染者的血浆替诺福韦暴露。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.01638-18. Print 2019 Apr.
5
Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017.估计美国跨性别群体中的 HIV 流行率和性行为:2006-2017 年的系统评价和荟萃分析。
Am J Public Health. 2019 Jan;109(1):e1-e8. doi: 10.2105/AJPH.2018.304727. Epub 2018 Nov 29.
6
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.长效注射型卡替拉韦在低危 HIV 未感染者中的安全性、耐受性和药代动力学:HPTN 077,一项 2a 期随机对照试验。
PLoS Med. 2018 Nov 8;15(11):e1002690. doi: 10.1371/journal.pmed.1002690. eCollection 2018 Nov.
7
A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies.对女性参与艾滋病病毒研究(纳入或排除)的系统评价:从抗逆转录病毒药物和疫苗的临床研究到治愈策略
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):181-8. doi: 10.1097/QAI.0000000000000842.
8
Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.HIV治愈临床研究中的性别、年龄、种族及干预类型:一项系统综述
AIDS Res Hum Retroviruses. 2015 Jan;31(1):85-97. doi: 10.1089/AID.2014.0205.
9
African ancestry influences CCR5 -2459G>A genotype-associated virologic success of highly active antiretroviral therapy.非洲血统影响 CCR5-2459G>A 基因型相关的高效抗逆转录病毒治疗的病毒学成功。
J Acquir Immune Defic Syndr. 2014 May 1;66(1):102-7. doi: 10.1097/QAI.0000000000000129.